Press Releases & In the News

News on emerging health issues, new trends in medicine and research, and connect with top experts at Mount Sinai.

Filter by:

Press Releases

In the News

Show All

General Pediatrics News

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

Mount Sinai at a Glance

400+ Community Locations

You can access Mount Sinai health care across New York City and beyond

Over 42,000 Employees

Including more than 7,400 primary care physicians and specialists

38 Institutes

Focused on multidisciplinary research, educational, and clinical progress

Instagram

In 1973, the Levy Library was officially dedicated to Gustave and Janet Levy, whose remarkable contributions helped shape Mount Sinai’s academic mission. By 1975, the reference deck had become a bustling hub of knowledge—card catalogs, reference desks, and quiet study corners were the tools of the time.

The 1980s brought rapid transformation. From the circulation desk that served as the heart of the library to the innovative Mediagraphies displays in 1981, Levy was constantly evolving. By mid-decade, dedicated staff were pushing forward new ways to support Mount Sinai’s academic needs. And in 1987, the debut of AV samples and the first computer menus marked the beginning of our digital future.

As we celebrate #LevyLibrary50, we’re also recognizing National Library Week, honoring the legacy and ongoing impact of libraries as essential spaces for discovery, community, and lifelong learning.

#NationalLibraryWeek #LibraryHistory #LevyLibrary

Instagram

Mount Sinai researchers, led by Dr. Robert Rosenson, have found that the RNA-based therapy zodasiran significantly reduces multiple harmful cholesterol and lipid levels in individuals with mixed hyperlipidemia, a major risk factor for heart disease. The ARCHES-2 clinical trial showed that zodasiran reduced triglycerides by up to 74%, lowered LDL cholesterol by up to 20%, cut non-HDL cholesterol by up to 36%, and decreased remnant cholesterol by up to 82%. Unlike traditional treatments, zodasiran works by silencing the ANGPTL3 gene, offering longer-lasting effects with fewer doses.

Published in The New England Journal of Medicine and presented at the European Atherosclerosis Society Congress, this study highlights the potential for RNA-based therapies to expand treatment options beyond statins. Researchers suggest that further studies could confirm zodasiran’s role in reducing cardiovascular risk and improving patient outcomes.

Read more in the full report via the link in our bio.
#RNATherapy #Cholesterol #Cardiology

Press Releases & In the News

Search General Pediatrics News

General Pediatrics News

400+ Community Locations

Over 42,000 Employees

38 Institutes